Adaptive Biotechnologies Corporation Common Stock
Symbol: ADPT (NASDAQ)
13.64
▲ (9.81%) 1.218
Company Description:
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).
Key Stats
- Today's Open: $12.49
- Today's High: $13.663
- Today's Low: $12.412
- Today's Volume: 1.02M
- Yesterday Close: $12.42
- Yesterday High: $13.015
- Yesterday Low: $12.34
- Yesterday Volume: 1.78M
- Last Min Volume: 7.24K
- Last Min High: $13.647
- Last Min Low: $13.61
- Last Min VWAP: $13.63001
Company Profile
- Name: Adaptive Biotechnologies Corporation Common Stock
- Website: https://www.adaptivebiotech.com
- Listed Date: 2019-06-27
- Location: SEATTLE, WA
- Market Status: Active
- CIK Number: 0001478320
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $1.89B
- Round Lot: 100
- Outstanding Shares: 152.27M
- Asset Type: CS
RECENT FILINGS FOR ADPT
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-18 | 8-K | View |
| 2025-08-05 | 10-Q | View |
| 2025-08-05 | 8-K | View |
| 2025-07-09 | SCHEDULE 13G/A | View |
| 2025-06-12 | 8-K | View |
| 2025-06-06 | SCHEDULE 13G/A | View |
| 2025-05-20 | 4/A | View |
| 2025-05-19 | 4 | View |
| 2025-05-14 | SCHEDULE 13G | View |
| 2025-05-07 | SCHEDULE 13G/A | View |
| 2025-05-05 | 4 | View |
| 2025-05-01 | 144 | View |
| 2025-05-01 | 10-Q | View |
| 2025-05-01 | 8-K | View |
| 2025-04-29 | ARS | View |
| 2025-04-29 | DEFA14A | View |
| 2025-04-29 | DEF 14A | View |
| 2025-04-17 | SCHEDULE 13G/A | View |
| 2025-03-26 | 4 | View |
| 2025-03-24 | 144 | View |
Latest News on ADPT